• Animal study shows effective protection of mitochondria from oxidative damage and reduced plaque vulnerability in advanced atherosclerosis following treatment with SOD2 mRNA nanoparticles based on Altamira's
A case-control study in Denmark suggests not only that there should be no concern about cardiovascular side effects from mRNA vaccines in patients with HF but also that vaccines provide a survival benefit.
Study under way to assess risk of Atherosclerotic Cardiovascular Disease in Pakistan
Karachi
May 2, 2021
One-fourth or 25 per cent of the South Asian Countries’ population is at an increased risk of developing Atherosclerotic Cardiovascular Disease (ASCVD), experts said recently, warning that prevalence of the disease continues to rise in South Asian countries, including Pakistan where ASCVD remains the leading cause of death.
Although Pakistan is the second most populous country in South Asia, most of the data on the prevalence of cardiovascular diseases from the South Asian region is derived from India, they said, adding that as a result, the Pakistani population is highly underrepresented in global research as there is currently no comprehensive database on the native Pakistani population to assess the likelihood of developing ASCVD.